As follows, here is a list of new cancer drugs that show especial promise. Herceptin or trastuzumab is a monoclonal antibody to the HER2 receptor and a recent innovation in breast cancer treatment. In those who have the mutation specific... (Continue reading)
Sutent – an exciting new cancer treatment Sutent, generic sunitinib, is a new cancer medication that has quickly become accepted as a first line treatment for renal cell carcinoma (RCC) as well as a treatment for gastrointestional stromal tumor (GIST)... (Continue reading)
Tarceva, generic erlotinib, is a new treatment for non-small cell lung cancer that works by targeting the epidermal growth factor receptor (EGFR). It doesn’t work that great and can cost up to $50,000 a year. As such, its class of... (Continue reading)
Iressa or gefitinib targets epidermal growth factor receptor and disrupts its intracellular behavior. This was hoped to have significant anti-cancer effects. Unfortunately, it seems increasingly that the clinical benefit of Iressa is limited. Although it showed some benefit in treating... (Continue reading)